CV Sciences Plans +PlusHLTH Launches Over 12 to 24 Months as Q3 Gross Margin Hits 50%

CV Sciences, Inc. plans several non-cannabinoid launches under its +PlusHLTH brand over the next 12 to 24 months, aiming to support organic growth and offset regulation-related revenue pressure.

The company recorded a 50% gross margin in the third quarter of 2026. Operating cash flow was about $64,000, and adjusted EBITDA was positive.

CEO, Secretary and Director Joseph Dowling said sales, gross margin, operating performance and adjusted EBITDA all increased sequentially. “This quarter, we increased sales, gross margin, operating performance, and adjusted EBITDA on a sequential basis,” Dowling said.